Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|December 23, 2024
NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapySerena Cecchetti, Cristina Federici, Rossella Canese, et al.
Biomed Research International|October 3, 2014
Lung cancer stem cell lose their stemness default state after exposure to microgravityMaria Elena Pisanu, Alessia Noto, Claudia De Vitis, et al.
Cell Proliferation|September 3, 2024
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cellsTeresa Rossi, Egidio Iorio, Mattea Chirico, et al.
NMR in Biomedicine|October 25, 2011
Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imagingRossella Canese, Maria Elena Pisanu, Delia Mezzanzanica, et al.
Aging Cell|June 7, 2022
Young transgenic hMTH1 mice are protected against dietary fat-induced metabolic stress-implications for enhanced longevityFrancesca Marcon, Roberta Meschini, Egidio Iorio, et al.
Oncotarget|September 15, 2017
Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer modelLuisa Paris, Franca Podo, Francesca Spadaro, et al.
Journal of Proteome Research|December 18, 2023
Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer SpecimensAlessandro Ricci, Matteo Dugo, Maria Elena Pisanu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2016
miR-579-3p controls melanoma progression and resistance to target therapyLuigi Fattore, Rita Mancini, Mario Acunzo, et al.
Nucleic Acids Research|December 17, 2013
Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesisErica Salvati, Pasquale Zizza, Angela Rizzo, et al.
Oncotarget|July 26, 2015
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanomaLuigi Fattore, Debora Malpicci, Emanuele Marra, et al.
Pageof 4